» Articles » PMID: 23255514

Controlled Ovarian Hyperstimulation for IVF: Impact on Ovarian, Endometrial and Cervical Cancer--a Systematic Review and Meta-analysis

Overview
Date 2012 Dec 21
PMID 23255514
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In response to the ongoing debate on the long-term effects of assisted reproduction technologies, such as IVF, we systematically reviewed and meta-analyzed available evidence on the association between controlled ovarian hyperstimulation for IVF and risk of ovarian, endometrial and cervical cancer.

Methods: Eligible studies were identified and pooled effect estimates for relative risk (RR) were calculated by cancer type among two reference groups (general population or infertile women), through fixed- or random-effects models as appropriate.

Results: Nine cohort studies were synthesized, corresponding to a total size of 109 969 women exposed to IVF, among whom 76 incident cases of ovarian, 18 of endometrial and 207 cases of cervical cancer were studied. The synthesis of studies with general population as the reference group pointed to a statistically significant positive association between IVF and increased risk for ovarian (RR = 1.50, 95% confidence interval (CI): 1.17-1.92) and endometrial (RR = 2.04, 95% CI: 1.22-3.43), but not cervical (RR = 0.86, 95% CI: 0.49-1.49) cancers. On the contrary, when infertile women were used as the reference group, no significant associations with ovarian, endometrial or cervical cancer types were noted (RR = 1.26, 95% CI: 0.62-2.55 RR = 0.45, 95% CI: 0.18-1.14 and RR = 5.70, 95% CI: 0.28-117.20, respectively).

Conclusions: IVF does not seem to be associated with elevated cervical cancer risk, nor with ovarian or endometrial cancer when the confounding effect of infertility was neutralized in studies allowing such comparisons. Of note, only one study provided follow-up longer than 10 years for the group exposed to IVF. Future cohort studies should preferably use infertile women as the reference group, rely on IVF-registered valid exposure data, adjust for a variety of meaningful confounders and adopt relatively longer follow-up periods before sound conclusions are drawn.

Citing Articles

The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer.

Ortmann O, Schuler-Toprak S, Kast K J Cancer Res Clin Oncol. 2024; 150(9):417.

PMID: 39259360 PMC: 11390776. DOI: 10.1007/s00432-024-05936-7.


Parental Inflammatory Bowel Disease with Child Autism: A Comprehensive Review and Meta-Analysis.

Wang X, Qian C, Yao H J Autism Dev Disord. 2024; .

PMID: 38976104 DOI: 10.1007/s10803-024-06458-4.


Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview.

Silvestris E, Cormio G, Loizzi V, Corrado G, Arezzo F, Petracca E Life (Basel). 2024; 14(5).

PMID: 38792636 PMC: 11122448. DOI: 10.3390/life14050615.


A Case Report of Consecutive Live Birth Twice Through in vitro Fertilization and Embryo Transfer After Endometrial Carcinoma Fertility Preservation Treatment.

Wang J, Fang Y, Chen T, Xin Z, Wu Y, Yang X Int J Womens Health. 2024; 16:395-400.

PMID: 38463685 PMC: 10924884. DOI: 10.2147/IJWH.S441984.


Causal effects of endometriosis on SLE, RA and SS risk: evidence from meta-analysis and Mendelian randomization.

Tang T, Zhong Y, Xu S, Yu H BMC Pregnancy Childbirth. 2024; 24(1):162.

PMID: 38395801 PMC: 10885476. DOI: 10.1186/s12884-024-06347-9.